#Italy #Vienna #Esaote #I-Genius #neuro-surgery

Esaote's Groundbreaking I-Genius System in Neuro-Surgery

Esaote, a prominent player in the field of medical imaging, has made a significant leap into neuro-surgery by introducing the I-Genius system, an innovative intraoperative MRI solution designed specifically for brain tumor operations. The unveiling took place during the 25th Annual Congress of the European Association of Neurosurgical Societies (EANS) in Vienna, from October 5 to 9, 2025. This move reflects Esaote’s ongoing commitment to improving medical imaging and advancing surgical techniques through collaboration with leading neuro-surgeons.

The Importance of I-Genius in Neuro-Surgery

In recent years, gliomas, the most common type of malignant brain tumors, have dominated the landscape of neuro-surgery. They account for about 81% of all malignant intracranial tumors, with glioblastomas representing around 45% of these cases. Unfortunately, glioblastomas have a dismal five-year survival rate of only 5%. The surgical challenge lies in effectively removing as much of the tumor as possible while minimizing damage to healthy brain tissue. Typically, imaging techniques are employed to identify any residual tumor after surgery, yet complications arise when the brain shifts due to the opening of the meninges and subsequent tissue removal.

I-Genius addresses these challenges by providing real-time imaging that maintains coherence between preoperative and intraoperative images. Traditional intraoperative MRI systems tend to be closed field and cumbersome, which complicates their use during surgeries. In contrast, I-Genius features an open design that facilitates easier access for neuro-surgeons, streamlining the surgical process.

Enhancing Surgical Efficiency and Safety

The I-Genius system is equipped with a specially designed surgical table that allows patients to remain stationary throughout the procedure. This design not only expedites the acquisition of MRI images but also minimizes the risk of complications associated with moving the patient. Surgeons can now confirm the complete removal of the tumor before closing the skull, greatly enhancing surgical efficiency.

Dr. Roberto Herrera, the head of Neuro-surgery at the Adventist Belgrano Clinic in Buenos Aires, shared his excitement about the I-Genius system, stating, "What is truly innovative about I-Genius is its ability to provide intraoperative images at every stage of the neuro-surgical operation. This ensures that the surgeon can resect the lesion, immediately check the outcome, and adjust the surgical approach safely with confidence. This process can be repeated as often as necessary, leading to a final confirmation that maximal resection has been safely achieved."

Esaote's Vision for the Future

Franco Fontana, CEO of Esaote, highlighted the significance of I-Genius in the company’s trajectory: "This marks a pivotal step for Esaote, resulting from our strategy based on technological innovation and applied research. The I-Genius system represents an accessible and sustainable solution that brings substantial value to neuro-surgical practice and aims to improve the quality of life for patients undergoing brain surgery."

With approximately 1,300 employees worldwide, half of whom are in Italy, Esaote invests about 13% of its consolidated revenue back into research and development each year. The company operates from facilities in Genoa and Florence and maintains its presence in over 100 countries globally. The introduction of I-Genius underscores Esaote's commitment to excellence in medical imaging and its focus on advancing patient care through innovative technology.

As the medical community continues to evolve, systems like I-Genius will undoubtedly play a crucial role in shaping the future of neuro-surgery, demonstrating the power of innovation to enhance surgical outcomes and improve patient experiences.